Lymphatic delivery of 99mTc-labeled dextran acetate particles including cyclosporine A

Journal of Microbiology and Biotechnology

Volumn 18, Issue 9, 2008, Pages 1599-1605

  Kim, Jin ^a   Chung, Kyong Hwan ^a   Lee, Chang Moon ^b   Seo, Young Soon ^c   Song, Ho Chun ^c   Lee, Ki Young ^a  

^a Chonnam National University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Cyclosporine A; Dextran acetate; Human serum albumin; Lymphatic delivery; Technetium 99m labeling

Indexed keywords

ACETIC ANHYDRIDE; CYCLOSPORIN A; DEXTRAN TC 99M; HUMAN SERUM ALBUMIN; CYCLOSPORIN; DEXTRAN; MACROSALB TC 99M; SERUM ALBUMIN; TECHNETIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG STABILITY; FEMALE; INGUINAL LYMPH NODE; ISOTOPE LABELING; LYMPHATIC SYSTEM; NONHUMAN; RAT; ANIMAL; INFRARED SPECTROSCOPY; LYMPH VESSEL; METABOLISM; METHODOLOGY; SCANNING ELECTRON MICROSCOPY; SCINTISCANNING; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

RATTUS;

ANIMALS; CYCLOSPORINE; DEXTRANS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; LYMPHATIC VESSELS; MICROSCOPY, ELECTRON, SCANNING; RADIONUCLIDE IMAGING; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNETIUM; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TISSUE DISTRIBUTION;

EID: 56649094306     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Albertini, J. J., G. H. Lyman, C. Cox, T. Yeatman, L. Balducci, and N. Ku. 1996. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 11: 1818-1822.
2. 99mTc dextran. Clin. Nucl. Med. 20: 1070-1073.
3. 99m dextran: A promising new proteinlosing enteropathy imaging agent. Eur. J. Nucl. Med. 23: 575-578.
4. 99mTc-dextran: A potential inflammation-seeking radiopharmaceutical. Nucl. Med. Commun. 16: 1058-1062.
5. 99mTc dextran. Clin. Nucl. Med. 23: 123-124.
6. Boinpally, R. R., S. L. Zhou, G. Devraj, P. K. Anne, S. Poondru, and D. R. Jasti. 2004. Iontophoresis of lecithin vesicles of cyclosporine A. Int. J. Pharm. 274: 185-190.
7. Caitriona, M. 2002. Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci. 15: 405-415.
8. Chacon, M., J. Molpeceres, L. Berges, M. Guzman, and M. R. Aberturas. 1999. Stability and freeze-drying of cyclosporine loaded poly(D,L-lactide-glycolide) carriers. Eur. J. Pharma. Sci. 8: 99-107.
9. 99m for use as a cardiac blood-pool imaging agent. Am. J. Hosp. Pharm. 15: 2797-2800.
10. 99mTc dextran 70 for lymphoscintigraphy. Clin. Nucl. Med. 25: 179-181.
11. 99mTc and its evaluation for lymphoscintigraphy. Nucl. Med. Biol. 20: 701-706.
12. Drewe, J., C. Beglinger, and T. Kissel. 1992. The absorption site of cyclosporine in the human gastrointestinal tract. Br. J. Clin. Pharmacol. 33: 39-43.
13. Drug Topics.com. http://www.drug-topics.com and search past issues.
14. 99mTc-labeled radiopharmaceuticals for sentinel lymph node identification. Nucl. Med. Commun. 22: 499-504.
15. 99mTc as a lymphoscintigraphic agent in rabbits. Eur. J. Nucl. Med. 11: 80-84.
16. Gao, Z. G., H. G. Choi, H. J. Shin, K. M. Park, S. J. Lim, K. J. Hwang, and C. K. Kim. 1998. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of CyA. Int. J. Pharm. 161: 75-86.
17. Guo, J., O. Ping, and Y. Chen. 2001. Pharmacokinetic behavior of cyclosporine A in rabbits by oral administration of lectin vesicle and Sandimmun Neoral. Int. J. Pharmaceut. 216: 17-21.
18. 99mTc dextran: A new blood-pool labeling agent for radionuclide angiocardiography. J. Nucl. Med. 23: 348-353.
19. 99mTc labelled dextran. J. Nucl. Med. 23: 923-929.
20. Holm R., C. J. H. Porter, G. A. Edwards, A. Mullertz, H. G. Kristensen, and W. N. Charman. 2003. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur. J. Pharm Sci. 20: 91-97.
21. Holmberg, A., M. Marquez, J.-E. Westlin, and S. Nilson. 1995. Labeling of polypeptides with technetium-99m using a dextran spacer. Cancer Res. 55: 5710-5713.
22. Jeong J. M., M. K. Hong, Y. J. Kim, J. Lee, J. H. Kang, D. S. Lee, J.-K. Chung, and M. C. Lee. 2004. Development of 99mTc-neomannosyl human serum albumin as a novel receptor binding agent for sentinel lymph node imaging. Nucl. Med. Commun. 25: 1211-1217.
23. Kao, C.-H., H.-T. Lin, S.-L. Yu, S.-J. Wang, and J.-L. Lan. 1995. Effects of corticosteroid inhalation therapy on the deposition pattern of Tc-99m human serum albumin radioaerosols in asthma. Lung 173: 291-296.
24. 99mTc dextran scintigraphy: A novel experience. Indian J. Pediatr. 69: 761-764.
25. Kim, C. K., S. A. Ryu, K. M. Park, S. J. Lim, and S. J. Hwang. 1997. Preparation and physicochemical characterization of phase inverted water/ oil microemulsion containing CyA. Int. J. Pharm. 147: 131-134.
26. Kumar, V. and G. S. Banker. 1996. Target-oriented drug delivery systems, pp. 662-663. In G. S. Banker and C. T. Rhodes (eds.), Modern Pharmaceutics. Marcel Dekker, New York.
27. Lee, C.-M., Y.-J. Heo, H.-C. Song, H.-S. Bom, H.-C. Lee, H.-J. Jeong, and K.-Y. Lee. 2007. Radioevaluation of PAMs, CMs, and PS-Lip as an oral carrier for vaccine delivery into intestinal Peyer's patches. Drug Develop. Res. 67: 1-6.
28. 99mTc-dextran antibody conjugates. Labeling procedures. Acta Oncol. 35: 489-492.
29. Matsunaga, K., K. Hara, T. Imamura, T. Fujioka, J. Takata, and Y. Karube. 2005. Technetium labeling of dextran loading cysteamine as a ligand. Nucl. Med. Biol. 32: 279-285.
30. McEvoy, G. K. (ed.). 1990. AHFS (American Hospital Formulary Services) Drug Information, pp. 2570-2576. American Society of Health-System Pharmacists, Bethesda, MD.
31. Miyake, K., H. Arima, T. Irie, F. Hiraayama, and K. Uekama. 1998. Enhanced adsorption of CyA by complexation with dimethyl-beta-cyclodextrin in bile duct cannulated and noncannulated rats. Biol. Pharm. Sci. 22: 66-72.
32. Motozato, Y., H. Ihara, T. Tomoda, and C. Hirayama. 1986. Preparation and gel permeation chromatographic properties of pulluan sphere. J. Chromatogr. 335: 434-437.
33. Murdan, S., T. Andrysek, and D. Son. 2005. Novel gels and their dispersions-oral drug delivery and systems for cyclosporine. Int. J. Pharm. 300: 113-124.
34. Neubauer, S., I. Mena, R. Iglesis, R. Schwartz, J. C. Acevedo, and A. Leon. 2001. Sentinel lymph node mapping in melanoma with technetium-99m dextran. Cancer Biother. Radiopharm. 16: 265-267.
35. Odeberg, J. M., P. Kaufmann, K. G. Kroon, and P. Hoglund. 2003. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability applied to cyclosporine. Eur. J. Pharm. Sci. 20: 375-382.
36. Park, K., W. S. E. Shalaby, and H. Park. 1993. Biodegradable Hydrogels for Drug Delivery. Technomic Publishing Inc., Lancaster.
37. Piato, J. R., A. C. Barros, K. M. Pincerato, A. P. Sampaio, and J. A. Pinotti. 2003. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur. J. Surg. Oncol. 29: 118-120.
38. Tejani, A. 1998. Neoral: The microemulsion formulation. Pediatr. Transplant. 2: 85-86.
39. Urata, T., K. Arimori, and H. Nakano. 1999. Modification of release rates of cyclosporine A from poly(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres. J. Control. Release 58: 133-141.
40. Vigario, A., M. T. Sapienza, A. P. Sampaio, J. R. Piato, N. Barros, and A. Barros. 2003. Primary chemotherapy effect in sentinel node detection in breast cancer. Clin. Nucl. Med. 28: 553-557.
41. Wang, X.-Q., J.-D. Dai, Z. Chen, T. Zhang, G.-M. Xia, T. Nagai, and Q. Zhang. 2004. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. J. Control. Release 97: 421-429.
42. Wang, X.-Q., J. Huang, J.-D. Dai, T. Zhang, W.-L. Lu, H. Zhang, X. Zhang, J.-C. Wang, and Q. Zhang. 2006. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid. In. J. Pharm. 322: 146-153.
43. William, N. C. and J. H. P. Christopher. 1996. Lipophilic prodrugs designed for intestinal lymphatic transport. Adv. Drug Deliv. Rev. 19: 149-169.
44. 99mTc-dextrans for lymphoscintigraphy. Eur. J. Nucl. Med. 15: 146-151.
45. 99mTc labeled dextran 500 and patent blue V dye. Nucl. Med. Commun. 22: 1109-1117.